15-min delayed · Jul 29, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering HUTCHMED DRC, 1 rate it Buy or better, 1 sit at Hold, and 1 rate it Sell or worse, a hold consensus. Targets are tightly clustered, $13.75 to $17.00, so the covering firms are broadly aligned. The average target of $15.38 sits 35% above the current $11.39. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.00 next quarter toward $0.36 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Hold
Strong Buy00%
Buy133%
Hold133%
Sell133%
Strong Sell00%
Based on 3 analysts giving stock ratings to HUTCHMED DRC.
As of Jul, 1 of 3 firms rate HCM a Buy (1 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
HCM EPS & revenue forecast
EPS · NEXT QUARTER
$0.00
Range $0.00 – $0.00 · 0 analysts
Next period, 0 analysts expect HUTCHMED DRC to earn $0.00 a share (range $0.00 – $0.00), versus — a year earlier. Full-year consensus is $0.26, growing to $0.36 the year after.
REVENUE · NEXT QUARTER
—
Range — – — · 0 analysts
Revenue is expected to reach — (range — – —). Full-year consensus is $630.9M, rising to $717.4M next year.
Top analysts covering HUTCHMED DRC
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on HCM.
#1
Dimple Gosai
B of A Securities
Buy
$20.00+75.5% to target
Coverage
—
+ Follow
#2
JL
Jack Lin
Morgan Stanley
Sell
$13.75+20.7% to target
Coverage
—
+ Follow
#3
Alec Stranahan
B of A Securities
Buy
$17.00+49.2% to target
Coverage
—
+ Follow
#4
Paul Choi
Goldman Sachs
Hold
$19.00+66.7% to target
Coverage
—
+ Follow
HCM stock forecast FAQ
What is HCM's average 12-month price target?+
The 2 analysts with a live target average $15.38 for HUTCHMED DRC over the next 12 months, ranging from a $17.00 high to a $13.75 low.
Is HCM stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 3 analyst ratings, 1 are Buy or Strong Buy, 1 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for HCM?+
The Street-high target is $17.00 (B of A Securities), and the Street-low is $13.75 (Morgan Stanley). The average of all 2 active targets is $15.38.
How many Wall Street analysts cover HCM?+
3 analysts have an active rating on HUTCHMED DRC, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering HCM?+
Among analysts who currently cover HCM, Dimple Gosai of B of A Securities has the strongest overall Quantellect track record. Their current call is Buy with a $20.00 target.
What is HUTCHMED DRC's projected EPS for next quarter?+
The consensus estimate is $0.00 per share (range $0.00 – $0.00) across 0 analysts. Full-year EPS is projected at $0.26, rising to $0.36 the following year.
How much revenue is HUTCHMED DRC expected to report next quarter?+
Consensus revenue is — (range — – —). Full-year revenue is projected at $630.9M, growing to $717.4M next year.
Have analysts been upgrading or downgrading HCM lately?+
As of Jul, 1 of 3 firms rate HCM a Buy (1 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their HCM calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
